FIELD: medicine; pharmacology.
SUBSTANCE: semifirm pharmaceutical compositions for local application include ascomycene in solution of carrier including three-componental admixture of dissolvents, component not less than 40% wt from lump of composition and consisting from: i) C3-8-alkanol and-or C1-8-alkandiol; ii) fat alcohol iii) additional dissolvents chosen from the family, containing:) alkyl ether of alkancarboxylic acid and-or alkyl ether alkandincarboxylic acid and-or a hydrophylic additional component and-or a triglyceride. Besides, the invention concerns application of the specified composition and the method of treatment of inflammatory and hyperproliferative diseases of skin and dermal implications of immunologically mediated diseases.
EFFECT: improvement of penetration of active substance.
9 cl, 7 tbl, 26 ex
Title | Year | Author | Number |
---|---|---|---|
PIMECROLIMUS FOAMY COMPOSITION INCLUDING HEXYLENE GLYCOL, OPTIONALLY OLEYL ALKOHOL AND/OR MEDIUM CHAIN TRIGLYCERIDES | 2005 |
|
RU2375044C2 |
ASCOMYCIN-CONTAINING COMPOSITIONS FOR TOPICAL APPLICATION | 1999 |
|
RU2234319C2 |
COMPOSITION FOR TOPICAL USE | 1995 |
|
RU2181592C2 |
PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2203058C2 |
ASCOMYCIN-CONTAINING OPHTHALMIC COMPOSITION | 2003 |
|
RU2322982C2 |
PREPARATION FOR TOPICAL USE FOR IMMUNOSUPPRESSION AND TREATMENT OF AUTOIMMUNE AND ALLERGIC DISEASES | 1996 |
|
RU2156127C2 |
PHARMACEUTICAL COMPOSITIONS COMPRISING COLLOIDAL SILICON DIOXIDE | 2002 |
|
RU2322970C2 |
PHARMACEUTICAL COMPOSITIONS | 1996 |
|
RU2159107C2 |
PHARMACEUTICAL COMPOSITION, USING CARBOXYLIC ACID FOR STABILIZING MACROLIDE IN THIS COMPOSITION AND METHOD FOR STABILIZING MACROLIDE | 1995 |
|
RU2292887C2 |
PHARMACEUTICAL CREAM COMPOSITION OF OXYMETAZOLINE FOR TREATING SYMPTOMS OF ROSACEA | 2012 |
|
RU2648439C2 |
Authors
Dates
2009-01-20—Published
2003-08-13—Filed